Sign Up to like & get
recommendations!
0
Published in 2017 at "Molecular Cancer Research"
DOI: 10.1158/1541-7786.mcr-17-0211
Abstract: Alterations in MEK1/2 occur in cancers, both in the treatment-naïve state and following targeted therapies, most notably BRAF and MEK inhibitors in BRAF-V600E–mutant melanoma and colorectal cancer. Efforts were undertaken to understand the effects of…
read more here.
Keywords:
inhibition;
braf inhibitor;
activity;
mek1 alterations ... See more keywords